CARRARO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 5.970
EU - Europa 2.789
AS - Asia 2.636
SA - Sud America 286
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 11.741
Nazione #
US - Stati Uniti d'America 5.926
SG - Singapore 856
CN - Cina 738
PL - Polonia 603
SE - Svezia 507
UA - Ucraina 406
IT - Italia 327
VN - Vietnam 269
BR - Brasile 219
HK - Hong Kong 219
TR - Turchia 171
FI - Finlandia 148
KR - Corea 147
FR - Francia 143
GB - Regno Unito 138
DE - Germania 132
RU - Federazione Russa 96
CH - Svizzera 66
IE - Irlanda 65
BG - Bulgaria 63
BD - Bangladesh 51
IN - India 47
NL - Olanda 30
AR - Argentina 21
IL - Israele 19
CA - Canada 18
MA - Marocco 18
BE - Belgio 17
JP - Giappone 15
VE - Venezuela 15
ES - Italia 14
IQ - Iraq 13
MX - Messico 13
PK - Pakistan 12
SA - Arabia Saudita 11
CL - Cile 10
UZ - Uzbekistan 9
EU - Europa 8
PH - Filippine 8
ZA - Sudafrica 8
ID - Indonesia 7
LT - Lituania 7
AT - Austria 6
EC - Ecuador 6
AU - Australia 5
AZ - Azerbaigian 5
CO - Colombia 5
PE - Perù 5
DZ - Algeria 4
JM - Giamaica 4
OM - Oman 4
TH - Thailandia 4
JO - Giordania 3
KZ - Kazakistan 3
SN - Senegal 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MV - Maldive 1
MY - Malesia 1
NA - Namibia 1
Totale 11.732
Città #
Fairfield 627
Woodbridge 562
Warsaw 536
Ashburn 532
Houston 518
Singapore 476
Ann Arbor 435
Chandler 355
Jacksonville 355
Wilmington 293
San Jose 281
Seattle 262
Hefei 237
Cambridge 222
Hong Kong 214
Beijing 162
Izmir 151
Seoul 146
Princeton 125
Boardman 106
Chicago 90
Ho Chi Minh City 87
Trieste 73
Columbus 66
Bern 65
Dublin 65
Sofia 63
Lauterbourg 61
Düsseldorf 59
Los Angeles 59
Zgierz 59
Hanoi 55
Moscow 50
San Diego 43
Dallas 42
Dearborn 42
Buffalo 38
Milan 38
Council Bluffs 36
Munich 34
The Dalles 31
London 28
Frankfurt am Main 22
New York 21
Helsinki 20
Santa Clara 20
Des Moines 18
Rome 18
São Paulo 18
Tel Aviv 18
Verona 17
Brussels 16
Nanjing 16
Phoenix 16
Guangzhou 15
Washington 15
Casablanca 14
Shanghai 14
Fremont 13
Haiphong 13
Norwalk 13
Atlanta 12
Orem 12
Falls Church 11
Turku 10
Auburn Hills 9
Rio de Janeiro 9
Tashkent 9
Tokyo 9
Da Nang 8
Denver 8
Brooklyn 7
Hangzhou 7
Miano 7
Pune 7
Redondo Beach 7
Belo Horizonte 6
Charlotte 6
Dong Ket 6
Fuzhou 6
Kunming 6
Montreal 6
San Francisco 6
Ankara 5
Baku 5
Chennai 5
Hebei 5
Jinan 5
Madrid 5
Nanchang 5
Porto Alegre 5
Salvador 5
Shenyang 5
Shenzhen 5
Tianjin 5
Barnet 4
Bến Tre 4
Erbil 4
Grafing 4
Istanbul 4
Totale 8.350
Nome #
The renal phenotype of allopurinol-treated HPRT-deficient mouse 461
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 450
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 343
Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS 281
Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes. 274
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury. 274
Hemicentin 1 influences podocyte dynamic changes in glomerular diseases 268
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 255
Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. 250
Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients. 247
Design and fabrication of large area nano-structured substrates for use in pancreatic beta-cell engineering 238
The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. 216
Mechanisms of malnutrition in uremia. 214
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 214
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: a novel model of glomerular damage. 204
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 203
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing 202
Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial 199
Proteomics of plasma and urine in primary nephrotic syndrome in children. 197
Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation 195
Role of components of frailty on quality of life in dialysis patients: a cross-sectional study. 193
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 190
Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. 185
Contrast agent nephrotoxicity: comparison of ionic and nonionic contrast agents 185
Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. 180
Evaluation of dietary compliance in patients with chronic renal failure on conservative treatment: comparison of methods to assess dietary intake 174
Contrast media nephrotoxicity: urinary protein and enzyme pattern in patients with or without saline infusion during digital subtracting angiography. 173
The assessment of nutritional status in chronically uremic patients 172
Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis 169
Characterization of plasma factor that alter albumin permeability in isolated glomeruli 168
Apheresis in primary focal segmental glomerulosclerosis of native and transplanted kidneys: a therapeutic protocol. 168
Involvement of the renin angiotensin system in the pathogenesis of postexercise proteinuria 166
Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome 166
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 166
Prospective and sequential study to establish the efficacy of rituximab therapy in maintaining remission of nephritic syndrome in patients with nephropathy at minimal injury or steroid-dependent, recurrent focal segmental glomerulosclerosis (NEMO) | Studio prospettico e sequenziale per stabilire l'efficacia della terapia con rituximab nel mantenere la remissione della sindrome nefrosica in pazienti con nefropatia a lesioni minime o glomerulosclerosi focale steroido-dipendenti o recidivanti (NEMO) 165
SNOM fluorescence techniques applied to cytoskeleton study in cell cultures 162
Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. 161
Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug 160
Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome 160
The role of kidney biopsy in the diagnosis of renal disease and renal masses 160
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier 159
Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach 157
An atypical presentation of a case of Horton's giant-cell arteritis 155
Inhibition of renal permeability towards albumin: a new function of apolipoproteins with possible pathogenetic relevance in focal glomerulosclerosis. 153
Recurrent autosomal-dominant focal segmental glomerulosclerosis 152
A clinical case. Primary renal amyloidosis 148
HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy 148
A comparison between an ionic paramagnetic contrast agent (Gd-DTPA) and a nonionic one (Gd-DTPA-BMA) in functional kidney evaluation with magnetic resonance 147
Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor. 147
Exercise-induced proteinuria. 146
Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target 143
Nifedipine reduces postexercise proteinuria in young volunteers. 142
Humoral permeability factors in the nephrotic syndrome: a compendium and prospectus. 142
Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome. 135
null 130
Extracorporeal photochemotherapy for the treatment of glomerulopathies with associated nephrotic syndrome. 127
null 124
Churg-Strauss vasculitis. A clinical case 118
The pathogenetical mechanism of glomerular proteinuria 115
Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. 114
Paraneoplastic syndromes and the kidney 109
Prophylactic perioperative plasmapheresis does not prevent rebound of permeability factors in patients with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplant 101
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile 101
Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence. 78
null 67
Totale 11.866
Categoria #
all - tutte 32.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.887


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 0 114
2021/2022710 28 47 74 87 16 66 29 28 84 75 60 116
2022/2023983 91 109 87 133 111 190 1 84 101 12 56 8
2023/2024545 92 42 27 61 51 41 81 94 3 3 31 19
2024/20251.128 14 11 41 142 124 177 43 61 132 123 97 163
2025/20263.055 289 228 240 286 213 294 370 106 413 418 133 65
Totale 11.866